Supriya Lifescience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 17 shareholders own 76.64% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
67.6%	Satish Wagh	54,441,315	₹37.6b	0%	no data
3.02%	Aditya Birla Sun Life AMC Limited	2,431,196	₹1.7b	-16.3%	0.09%
1.99%	Nippon Life India Asset Management Limited	1,603,832	₹1.1b	0%	0.03%
1.89%	Hornbill Capital Advisers LLP	1,520,000	₹1.0b	0%	18.75%
1.13%	Dovetail India Fund Class 6 Shares	912,384	₹629.9m	0%	27.84%
0.4%	Smita Wagh	321,750	₹222.1m	0%	no data
0.15%	Dimensional Fund Advisors LP	120,179	₹83.0m	2.71%	no data
0.13%	Saloni Wagh	102,375	₹70.7m	0%	no data
0.13%	Shivani Wagh	102,375	₹70.7m	0%	no data
0.068%	Motilal Oswal Asset Management Company Limited	54,770	₹37.8m	21.8%	no data
0.046%	Quantum Asset Management Company Private Limited	36,865	₹25.4m	36.7%	0.16%
0.032%	State Street Global Advisors, Inc.	25,778	₹17.8m	0%	no data
0.01%	Mellon Investments Corporation	8,329	₹5.8m	6.39%	no data
0.00037%	Groww Asset Management Limited	298	₹205.6k	26.3%	no data
0.00018%	American Century Investment Management Inc	144	₹100.0k	0%	no data
0.00005%	Bandhan AMC Limited	44	₹27.8k	0%	no data
0.00001%	Supriya Pharmaceuticals Partnership Firm	10	₹5.6k	0%	no data